Medicamen Organ. vs Sun Pharmaceutical Industries Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Medicamen Organ. currently has the stronger revenue growth signal.
Medicamen Organ. show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Medicamen Organ. | Sun Pharmaceutical Industries Ltd |
|---|---|---|
| Current Price | ₹25.6 | ₹1,944 |
| Market Cap | ₹34.55 Cr. | ₹4.66 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | — | 36.92 |
| ROE (%) | -13.66 | 15.95 |
| Debt/Equity | 0.5 | 0.06 |
| Sales Growth 5Y (%) | — | 11.78 |
| Profit Growth 5Y (%) | 13.6 | 14.45 |
| Promoter Holding (%) | 54.89 | 54.48 |
| Revenue Rank | Rank 1 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | No information |
| Fundraise | No | No information |